Evidence map›Paper›PMID 28630340›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Enhancing T

Valeria S Marangoni, Oara Neumann, Luke Henderson, Caterina C Kaffes, Hui Zhang, Runmin Zhang, Sandra Bishnoi, Ciceron Ayala-Orozco, Valtencir Zucolotto, James A Bankson and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Enzyme-Activated MRI for In Vivo Glucose Imaging via a Biodegradable Chromium Nanoprobe.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Carbon Dots Meet MRI: Metal Doping for a Smart Contrast Agent Design.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Nanotechnology in interventional cardiology: A state-of-the-art review.International journal of cardiology. Heart & vasculature · 2022
    Review
  11. Article
  12. GdProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cross-Link-Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2020
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Valeria S MarangoniDepartment of Chemistry, Rice University, Houston, TX 77005.
Oara NeumannDepartment of Electrical and Computer Engineering, Rice University, Houston, TX 77005.
Luke HendersonDepartment of Chemistry, Rice University, Houston, TX 77005.
Caterina C KaffesDepartment of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030.
Hui ZhangLaboratory for Nanophotonics, Rice University, Houston, TX 77005.
Runmin ZhangLaboratory for Nanophotonics, Rice University, Houston, TX 77005.
Sandra BishnoiDepartment of Chemistry, Rice University, Houston, TX 77005.
Ciceron Ayala-OrozcoDepartment of Chemistry, Rice University, Houston, TX 77005.
Valtencir ZucolottoSao Carlos Institute of Physics, University of Sao Paulo, Sao Carlos, Sao Paulo 13566-590, Brazil.
James A BanksonDepartment of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030.ORCID 0000-0002-8574-154X
Peter NordlanderLaboratory for Nanophotonics, Rice University, Houston, TX 77005.
Naomi J HalasDepartment of Chemistry, Rice University, Houston, TX 77005; halas@rice.edu.

Funding

Preclinical platform for theranostic nanoparticles in pancreatic cancerU01CA151886 · NCI · RICE UNIVERSITY · PI HALAS, NANCY J · 2010 to 2014
$1.7M
NCI NIH HHS U01 CA151886
6 · The paper itself

Abstract

Multifunctional nanoparticles for biomedical applications have shown extraordinary potential as contrast agents in various bioimaging modalities, near-IR photothermal therapy, and for light-triggered therapeutic release processes. Over the past several years, numerous studies have been performed to synthesize and enhance MRI contrast with nanoparticles. However, understanding the MRI enhancement mechanism in a multishell nanoparticle geometry, and controlling its properties, remains a challenge. To systematically examine MRI enhancement in a nanoparticle geometry, we have synthesized MRI-active Au nanomatryoshkas. These are Au core-silica layer-Au shell nanoparticles, where Gd(III) ions are encapsulated within the silica layer between the inner core and outer Au layer of the nanoparticle (Gd-NM). This multifunctional nanoparticle retains its strong near-IR Fano-resonant optical absorption properties essential for photothermal or other near-IR light-triggered therapy, while simultaneously providing increased T

Indexed as

Models, TheoreticalAnimalsContrast MediaGadoliniumGoldHumansMagnetic Resonance ImagingMetal NanoparticlesContrast MediaGadoliniumGoldAu nanoparticlegadoliniumrelaxivityT1 MRI contrast

Identifiers

PMID28630340
PMCPMC5502613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.